Regular use of short-acting calcium channel blockers, such as Nifedipine, Amlodipine, and Verapamil, may facilitate the onset of pancreatic cancer in postmenopausal women.
This study examined the correlation between the use of antihypertensive drugs and the risk of pancreatic cancer in women. A total of 145,551 women participated in this study and were assessed for their intake of antihypertensive medications and incidence of pancreatic cancer.
Researchers observed that postmenopausal women who took short-acting calcium channel blockers (CCBs), such as Nifedipine, Amlodipine, and Verapamil for 3 or more years had 107% higher chances of acquiring pancreatic cancer. Evidence from this study show that the use of short-acting calcium channel blockers may fuel the development of pancreatic cancer in postmenopausal women.